Omada Health (OMDA) – Investment Analysts’ Weekly Ratings Changes

Omada Health (NASDAQ: OMDA) recently received a number of ratings updates from brokerages and research firms:

• 3/14/2026 – Omada Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 3/12/2026 – Omada Health had its price target lowered by JPMorgan Chase & Co. from $32.00 to $26.00. They now have an “overweight” rating on the stock.
• 3/6/2026 – Omada Health had its price target lowered by Canaccord Genuity Group Inc. from $28.00 to $22.00. They now have a “buy” rating on the stock.
• 3/6/2026 – Omada Health had its price target lowered by BMO Capital Markets from $27.00 to $18.00. They now have an “outperform” rating on the stock.
• 3/6/2026 – Omada Health had its price target lowered by Morgan Stanley from $32.00 to $30.00. They now have an “overweight” rating on the stock.
• 3/3/2026 – Omada Health had its price target lowered by Barclays PLC from $22.00 to $17.00. They now have an “overweight” rating on the stock.

Insider Transactions at Omada Health

In related news, CEO Sean P. Duffy sold 4,063 shares of the business’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $14.34, for a total value of $58,263.42. Following the sale, the chief executive officer directly owned 117,598 shares of the company’s stock, valued at approximately $1,686,355.32. The trade was a 3.34% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, President Wei-Li Shao sold 5,618 shares of Omada Health stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $16.13, for a total value of $90,618.34. Following the completion of the sale, the president directly owned 69,079 shares in the company, valued at $1,114,244.27. This represents a 7.52% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 282,840 shares of company stock valued at $4,421,313 over the last 90 days.

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.